A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine

NCT07018700 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

990

Enrollment

INDUSTRY

Sponsor class

Conditions

Episodic Migraine

Interventions

DRUG: Xeomin
DRUG: Placebo

Sponsor

Merz Therapeutics GmbH